e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
54.65
-0.29 (-0.53%)
Official Closing Price
Updated: 7:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,704,438
Open
54.98
Bid (Size)
54.65 (200)
Ask (Size)
54.70 (5,000)
Prev. Close
54.94
Today's Range
54.23 - 55.18
52wk Range
42.52 - 63.33
Shares Outstanding
2,222,113,553
Dividend Yield
4.54%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Under-the-Radar Biotech Stocks Set to Boom in 2026
↗
Today 14:20 EST
Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.
Via
The Motley Fool
Topics
ETFs
Intellectual Property
World Trade
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
↗
January 23, 2026
Artificial intelligence may be all the rage in the technology sector, but it's also having a huge impact on healthcare.
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
+2.2%
+2.2%
1 Month
-0.1%
-0.1%
3 Month
+24.7%
+24.7%
6 Month
+12.8%
+12.8%
1 Year
-7.6%
-7.6%
More News
Read More
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
January 23, 2026
Via
The Motley Fool
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock With a Path to Growth
↗
January 17, 2026
Via
Chartmill
The Best Stocks to Invest $1,000 in Right Now
↗
January 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
2 Dividend Stocks to Buy and Hold For 10 Years
↗
January 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Buffett Stocks to Load Up On—And 1 to Ditch
↗
January 19, 2026
Via
MarketBeat
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Thursday's session: gap up and gap down stock in the S&P500 index
↗
January 15, 2026
Via
Chartmill
3 Value Stocks That Fall Short
January 14, 2026
Via
StockStory
3 S&P 500 Stocks Walking a Fine Line
January 13, 2026
Via
StockStory
Topics
Stocks
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
January 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
January 12, 2026
From
Bristol Myers Squibb
Via
Business Wire
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
3 Drug Stocks to Buy at a Discount
↗
January 07, 2026
Via
The Motley Fool
Discover which S&P500 stocks are making waves on Wednesday.
↗
January 07, 2026
Via
Chartmill
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
1 Top ETF I Plan to Load Up on in 2026
↗
January 02, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 02, 2026
From
Bristol Myers Squibb
Via
Business Wire
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 54.65
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 01/23/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 121.44B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 121B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert